• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三结构域蛋白 3A 通过增强 TLR4 和 TLR9 的泛素化介导降解来减轻病理性心肌肥厚。

Triad3A attenuates pathological cardiac hypertrophy involving the augmentation of ubiquitination-mediated degradation of TLR4 and TLR9.

机构信息

Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center For Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, 211166, China.

Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.

出版信息

Basic Res Cardiol. 2020 Feb 1;115(2):19. doi: 10.1007/s00395-020-0779-1.

DOI:10.1007/s00395-020-0779-1
PMID:32008145
Abstract

Activation of TLRs mediated the NF-κB signaling pathway plays an important pathophysiological role in cardiac hypertrophy. Triad3A, a ubiquitin E3 ligase, has been reported to negatively regulate NF-κB activation pathway via promoting ubiquitination and degradation of TLR4 and TLR9 in innate immune cells. The role of Triad3A in cardiac hypertrophic development remains unknown. The present study investigated whether there is a link between Triad3A and TLR4 and TLR9 in pressure overload induced cardiac hypertrophy. We observed that Triad3A levels were markedly reduced following transverse aortic constriction (TAC) induced cardiac hypertrophy. Similarly, stimulation of neonatal rat cardiac myocytes (NRCMs) with angiotensin-II (Ang II) significantly decreased Triad3A expression. To determine the role of Triad3A in TAC-induced cardiac hypertrophy, we transduced the myocardium with adenovirus expressing Triad3A followed by induction of TAC. We observed that increased expression of Triad3A significantly attenuated cardiac hypertrophy and improved cardiac function. To investigate the mechanisms by which Triad3A attenuated cardiac hypertrophy, we examined the Triad3A E3 ubiquitination on TLR4 and TLR9. We found that Triad3A promoted TLR4 and TLR9 degradation through ubiquitination. Triad3A mediated TLR4 and TLR9 degradation resulted in suppression of NF-κB activation. Our data suggest that Triad3A plays a protective role in the development of cardiac hypertrophy, at least through catalyzing ubiquitination-mediated degradation of TLR4 and TLR9, thus negatively regulating NF-κB activation.

摘要

TLRs 介导的 NF-κB 信号通路的激活在心脏肥大的病理生理过程中发挥着重要作用。泛素 E3 连接酶 Triad3A 已被报道通过促进先天免疫细胞中 TLR4 和 TLR9 的泛素化和降解来负调控 NF-κB 激活途径。Triad3A 在心脏肥大发展中的作用尚不清楚。本研究探讨了 Triad3A 与 TLR4 和 TLR9 之间在压力超负荷诱导的心脏肥大中的关系。我们观察到,在主动脉缩窄(TAC)诱导的心脏肥大后,Triad3A 水平明显降低。同样,血管紧张素-II(Ang II)刺激新生大鼠心肌细胞(NRCMs)也显著降低了 Triad3A 的表达。为了确定 Triad3A 在 TAC 诱导的心脏肥大中的作用,我们用表达 Triad3A 的腺病毒转导心肌,然后进行 TAC 诱导。我们观察到,Triad3A 的表达增加显著减轻了心脏肥大并改善了心脏功能。为了研究 Triad3A 减轻心脏肥大的机制,我们检查了 Triad3A 对 TLR4 和 TLR9 的 E3 泛素化作用。我们发现 Triad3A 通过泛素化促进 TLR4 和 TLR9 的降解。Triad3A 介导的 TLR4 和 TLR9 降解导致 NF-κB 激活受到抑制。我们的数据表明,Triad3A 在心脏肥大的发展中发挥保护作用,至少通过催化 TLR4 和 TLR9 的泛素化介导的降解,从而负调控 NF-κB 的激活。

相似文献

1
Triad3A attenuates pathological cardiac hypertrophy involving the augmentation of ubiquitination-mediated degradation of TLR4 and TLR9.三结构域蛋白 3A 通过增强 TLR4 和 TLR9 的泛素化介导降解来减轻病理性心肌肥厚。
Basic Res Cardiol. 2020 Feb 1;115(2):19. doi: 10.1007/s00395-020-0779-1.
2
Triad3A-Mediated K48-Linked ubiquitination and degradation of TLR9 impairs mitochondrial bioenergetics and exacerbates diabetic cardiomyopathy.三型衔接蛋白 3A(Triad3A)介导的 TLR9 的 K48 连接泛素化和降解,损害线粒体生物能量学,并加剧糖尿病性心肌病。
J Adv Res. 2024 Jul;61:65-81. doi: 10.1016/j.jare.2023.08.015. Epub 2023 Aug 23.
3
A cathelicidin-related antimicrobial peptide suppresses cardiac hypertrophy induced by pressure overload by regulating IGFR1/PI3K/AKT and TLR9/AMPKα.一种抗菌肽通过调节 IGFR1/PI3K/AKT 和 TLR9/AMPKα 抑制压力超负荷诱导的心肌肥厚。
Cell Death Dis. 2020 Feb 6;11(2):96. doi: 10.1038/s41419-020-2296-4.
4
Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.雌激素通过增加钙调神经磷酸酶降解的雌激素受体依赖性途径减轻左心室和心肌细胞肥大。
Circ Res. 2009 Jan 30;104(2):265-75, 11p following 275. doi: 10.1161/CIRCRESAHA.108.190397. Epub 2008 Dec 12.
5
Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.黄芩素通过抑制小鼠体内的AKT/mTOR、ERK1/2、NF-κB和钙调神经磷酸酶信号通路减轻血管紧张素II诱导的心脏重塑。
Am J Hypertens. 2015 Apr;28(4):518-26. doi: 10.1093/ajh/hpu194. Epub 2014 Oct 31.
6
Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways.羽扇豆醇通过 TLR4-PI3K-Akt-NF-κB 通路保护心肌肥厚。
Acta Pharmacol Sin. 2022 Aug;43(8):1989-2002. doi: 10.1038/s41401-021-00820-3. Epub 2021 Dec 16.
7
Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors.Triad3A,一种调节Toll样受体的E3泛素蛋白连接酶。
Nat Immunol. 2004 May;5(5):495-502. doi: 10.1038/ni1066. Epub 2004 Apr 25.
8
Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.Toll 样受体-2 通过核因子 κB 激活介导白细胞介素-1β 的上调,从而介导对压力超负荷的适应性心肌肥厚。
J Am Heart Assoc. 2013 Nov 18;2(6):e000267. doi: 10.1161/JAHA.113.000267.
9
Superoxide scavenging and Akt inhibition in myocardium ameliorate pressure overload-induced NF-κB activation and cardiac hypertrophy.超氧阴离子清除和心肌 Akt 抑制可改善压力超负荷诱导的 NF-κB 激活和心肌肥厚。
Physiol Genomics. 2010 Apr 1;41(2):127-36. doi: 10.1152/physiolgenomics.00202.2009. Epub 2010 Jan 26.
10
A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway.一种解整合素金属蛋白酶-22 通过抑制蛋白激酶 B 信号通路来减轻小鼠的肥大重构。
J Am Heart Assoc. 2018 Jan 22;7(2):e005696. doi: 10.1161/JAHA.117.005696.

引用本文的文献

1
CMTM7 inhibits TLR4 signaling pathway via promoting Rab5 activation and alleviates acute liver injury.CMTM7通过促进Rab5激活来抑制TLR4信号通路,并减轻急性肝损伤。
Cell Mol Life Sci. 2025 Jun 9;82(1):229. doi: 10.1007/s00018-025-05748-z.
2
Listerin Alleviates Alzheimer's Disease through IRE1-mediated Decay of TLR4 mRNA.利斯特菌素通过IRE1介导的TLR4 mRNA降解减轻阿尔茨海默病。
Adv Sci (Weinh). 2025 Aug;12(32):e14956. doi: 10.1002/advs.202414956. Epub 2025 May 31.
3
QRICH1 regulates ATF6 transcription to affect pathological cardiac hypertrophy progression.
QRICH1调节ATF6转录以影响病理性心肌肥厚进展。
Mol Med. 2025 May 13;31(1):183. doi: 10.1186/s10020-025-01241-2.
4
ECSIT-X4 is Required for Preventing Pressure Overload-Induced Cardiac Hypertrophy via Regulating Mitochondrial STAT3.通过调节线粒体 STAT3,ECSIT-X4 是预防压力超负荷诱导的心脏肥大所必需的。
Adv Sci (Weinh). 2025 Feb;12(8):e2414358. doi: 10.1002/advs.202414358. Epub 2025 Jan 2.
5
TRIM35 triggers cardiac remodeling by regulating SLC7A5-mediated amino acid transport and mTORC1 activation in fibroblasts.TRIM35 通过调节成纤维细胞中 SLC7A5 介导的氨基酸转运和 mTORC1 激活来触发心脏重构。
Cell Commun Signal. 2024 Sep 20;22(1):444. doi: 10.1186/s12964-024-01826-0.
6
Adaptor molecules mediate negative regulation of macrophage inflammatory pathways: a closer look.衔接分子介导巨噬细胞炎症途径的负调控:深入观察。
Front Immunol. 2024 Feb 28;15:1355012. doi: 10.3389/fimmu.2024.1355012. eCollection 2024.
7
Triad3A-Mediated K48-Linked ubiquitination and degradation of TLR9 impairs mitochondrial bioenergetics and exacerbates diabetic cardiomyopathy.三型衔接蛋白 3A(Triad3A)介导的 TLR9 的 K48 连接泛素化和降解,损害线粒体生物能量学,并加剧糖尿病性心肌病。
J Adv Res. 2024 Jul;61:65-81. doi: 10.1016/j.jare.2023.08.015. Epub 2023 Aug 23.
8
Toll-like receptors in cardiac hypertrophy.心脏肥大中的Toll样受体
Front Cardiovasc Med. 2023 Apr 11;10:1143583. doi: 10.3389/fcvm.2023.1143583. eCollection 2023.
9
Targeting WWP1 ameliorates cardiac ischemic injury by suppressing KLF15-ubiquitination mediated myocardial inflammation.靶向 WWP1 通过抑制 KLF15 泛素化介导的心肌炎症改善心脏缺血性损伤。
Theranostics. 2023 Jan 1;13(1):417-437. doi: 10.7150/thno.77694. eCollection 2023.
10
SENP1 Protects Against Pressure Overload-Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling.SENP1 通过抑制 STAT3 信号转导防止压力超负荷诱导的心脏重构和功能障碍。
J Am Heart Assoc. 2022 Nov 15;11(22):e027004. doi: 10.1161/JAHA.122.027004. Epub 2022 Nov 12.